Avadel Pharmaceuticals PLC (AVDL)
17.66
-0.43
(-2.38%)
USD |
NASDAQ |
Apr 24, 16:00
17.66
0.00 (0.00%)
After-Hours: 20:00
Avadel Pharmaceuticals Gross Profit (Quarterly): 18.76M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 18.76M |
September 30, 2023 | 6.897M |
June 30, 2023 | 1.46M |
March 31, 2023 | |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 | 0.00 |
September 30, 2020 | 0.00 |
June 30, 2020 | 6.806M |
March 31, 2020 | 9.786M |
December 31, 2019 | 8.581M |
September 30, 2019 | 11.41M |
June 30, 2019 | 13.93M |
March 31, 2019 | 13.17M |
December 31, 2018 | 16.63M |
September 30, 2018 | 16.71M |
June 30, 2018 | 25.72M |
March 31, 2018 | 26.70M |
December 31, 2017 | 30.70M |
Date | Value |
---|---|
September 30, 2017 | 35.88M |
June 30, 2017 | 41.75M |
March 31, 2017 | 48.60M |
December 31, 2016 | 40.49M |
September 30, 2016 | 29.24M |
June 30, 2016 | 34.95M |
March 31, 2016 | 32.31M |
December 31, 2015 | 41.63M |
September 30, 2015 | 45.23M |
June 30, 2015 | 45.85M |
March 31, 2015 | 29.10M |
December 31, 2014 | -7.192M |
September 30, 2014 | 5.115M |
June 30, 2014 | 3.811M |
March 31, 2014 | 3.805M |
December 31, 2013 | -8.633M |
September 30, 2013 | 3.847M |
June 30, 2013 | 4.258M |
March 31, 2013 | 4.145M |
December 31, 2012 | -7.292M |
September 30, 2012 | 3.898M |
June 30, 2012 | 4.486M |
March 31, 2012 | 6.042M |
December 31, 2011 | 6.799M |
September 30, 2011 | 9.305M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
Sep 2020
18.76M
Maximum
Dec 2023
5.971M
Average
6.806M
Median
Jun 2020
Gross Profit (Quarterly) Benchmarks
Trinity Biotech PLC | 4.28M |
Medtronic PLC | 5.307B |
Biophytis SA | -- |
Jazz Pharmaceuticals PLC | 904.69M |
DBV Technologies SA | -- |